Literature DB >> 8438219

Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions.

L Muylle1, M Joos, E Wouters, R De Bock, M E Peetermans.   

Abstract

Increased interleukin 6 (IL-6) levels were found in 8 of 12 platelet concentrates (PCs) after 3 days of storage and in 10 of 12 PCs after 5 and 7 days of storage. Most of the PCs with an increased IL-6 level also showed increased tumor necrosis factor alpha (TNF alpha) and interleukin 1 beta (IL-1 beta) levels. Levels of IL-6 increased by 3 log10 over the base level during storage. Increased levels were found when the PC white cell count exceeded 3 x 10(9) per L. A linear correlation was found among the levels of TNF alpha, IL-1 beta, IL-1 alpha, and IL-6 in the PCs (r > 0.885). Comparison of the TNF alpha, IL-1 beta, and IL-6 levels in samples taken at various storage times indicates that the increased levels are the result of an active synthesis and release of interleukins during storage. In a second part of the study, 45 transfusions of white cell-reduced PCs were studied. Six transfusions were complicated by a febrile reaction. These reactions were related to high levels of IL-6 and TNF alpha in the PCs (p < 0.0001). These cytokines are known as endogenous pyrogens. These findings indicate that transfusion reactions might be due to the intravenous administration of plasma with high cytokine levels and might not always result from an antigen-antibody reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438219     DOI: 10.1046/j.1537-2995.1993.33393174443.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  26 in total

1.  Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood System™

Authors:  Johannes Irsch; Lily Lin
Journal:  Transfus Med Hemother       Date:  2011-01-27       Impact factor: 3.747

2.  Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.

Authors:  Nahreen Tynngård; Agneta Wikman; Michael Uhlin; Per Sandgren
Journal:  Blood Transfus       Date:  2019-07-04       Impact factor: 3.443

Review 3.  Duration of red blood cell storage and inflammatory marker generation.

Authors:  Caroline Sut; Sofiane Tariket; Ming Li Chou; Olivier Garraud; Sandrine Laradi; Hind Hamzeh-Cognasse; Jerard Seghatchian; Thierry Burnouf; Fabrice Cognasse
Journal:  Blood Transfus       Date:  2017-03       Impact factor: 3.443

Review 4.  Platelet-rich plasma in the foot and ankle.

Authors:  Peter R Henning; Benjamin J Grear
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

Review 5.  Considerations for the use of platelet-rich plasma in orthopedics.

Authors:  Taralyn M McCarrel; Nathan A Mall; Andrew S Lee; Brian J Cole; Davietta C Butty; Lisa A Fortier
Journal:  Sports Med       Date:  2014-08       Impact factor: 11.136

6.  Time Dependent Release of Interleukin-8 and Tumor Necrosis Factor-α in Platelet Concentrate.

Authors:  Rinku V Shukla; Tanvi G Patel; Snehalata C Gupte
Journal:  Indian J Hematol Blood Transfus       Date:  2014-07-30       Impact factor: 0.900

7.  Melanoma cell metastasis via P-selectin-mediated activation of acid sphingomyelinase in platelets.

Authors:  Katrin Anne Becker; Nadine Beckmann; Constantin Adams; Gabriele Hessler; Melanie Kramer; Erich Gulbins; Alexander Carpinteiro
Journal:  Clin Exp Metastasis       Date:  2016-10-15       Impact factor: 5.150

Review 8.  CD40 ligand (CD154) involvement in platelet transfusion reactions.

Authors:  J Sahler; S Spinelli; R Phipps; N Blumberg
Journal:  Transfus Clin Biol       Date:  2012-06-14       Impact factor: 1.406

9.  Difference in autologous blood transfusion-induced inflammatory responses between acute normovolemic hemodilution and preoperative donation.

Authors:  Yoshifumi Kotake; Michiko Yamamoto; Midori Matsumoto; Takashige Yamada; Hiromasa Nagata; Hiroshi Morisaki; Junzo Takeda
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

10.  Leukoreduced blood components: Advantages and strategies for its implementation in developing countries.

Authors:  R R Sharma; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.